Skip to Content
MDPIMDPI
Medicina
Submit to Medicina

Journal History

1920 The inaugural issue of the Lithuanian-language journal Medicina (Kaunas, Lithuania) was released. Medicina was published as a monthly journal. 
1923 The abstracts of all articles were published in German.
1941–1944 As a result of political changes, Medicina was renamed twice within this period (L.T.S.R. Medicina and Lietuviškoji Medicina).
1944 Publication of the journal was suspended until the re-establishment of Lithuanian independence in 1990.
1989 The re-established Lithuanian Medical Association decided to resume the publication of Medicina.
1990 Medicina published its first issue after its 46-year break.
2001 Under a tripartite agreement among Kaunas University of Medicine, Lithuanian Medical Association and Vilnius University, the journal was reorganized.
Medicina became an open access journal.
2002 Medicina became the first Lithuanian scientific journal to be indexed in Index Medicus and MEDLINE.
2009 Medicina received its first Impact Factor (0.506).
2012 From this year onward, all articles in Medicina are published in English only.
2014 Elsevier became the publisher of Medicina. The journal adopted a bimonthly publication schedule.
2018 Publication of Medicina was transferred to MDPI from Volume 54, Issue 1 (2018).
Medicina adopted a monthly publication schedule.
In June, Medicina launched its first Special Issue.
2020 Medicina established the following sections:
  • Translational Medicine;
  • Sports Medicine;
  • Oncology;
  • Immunology;
  • Cardiology;
  • Neurology;
  • etc.
The journal announced the first edition of the Best Paper Award.
Medicina published its 1,000th paper.
2021 Medicina received its 2020 Impact Factor (2.430), ranked 80/196 (Q2) in “Medicine, General & Internal” category; The CiteScore (2020) increased to 1.7.
2022 Medicina received its 2021 Impact Factor (2.948); The CiteScore (2021) increases to 2.7.
2023 Medicina received its 2022 Impact Factor (2.6); The CiteScore (2022) increased to 3.6.
Section Immunology was renamed as Hematology and Immunology.
Section Nephrology was renamed as Urology & Nephrology.
Section Genetics was renamed as Genetics and Molecular Medicine.
Medicina established the following section:
  • Orthopedics.
Section Sports Medicine was renamed as Sports Medicine and Sports Traumatology.
Section Biochemistry and Pharmacology was renamed as Pharmacology.
2024 Medicina received its 2023 Impact Factor (2.4), ranking in Q1 80/325 in the "Medicine, General & Internal" category.
Medicina received its CiteScore (2023) of 3.3, ranked 80/325 (Q1) in “General Medicine”.

Editor-in-Chief

1920–1922 Editor-in-Chief: Dr. Juozas Žemgulys
1922–1944 Editor-in-Chief: Dr. Jonas Staugaitis
1990–2001 Editor-in-Chief: Prof. Dr. Zigmantas Satkevičius
2001–2013 Editor-in-Chief: Prof. Habil. Dr. Vilius Grabauskas
2013–present Editor-in-Chief: Prof. Dr. Edgaras Stankevičius

Section Editor-in-Chief

2021–2023 Section Editor-in-Chief: Prof. Dr. Aron-Frederik Popov for the section on Surgery
Section Editor-in-Chief: Prof. Dr. Johannes Mayr for the section on Pediatrics
2021–2024 Section Editor-in-Chief: Prof. Dr. Ann M. Møller for the section on Intensive Care/ Anesthesiology
2023–2025 Section Editor-in-Chief: Prof. Dr. Manfredi Rizzo for the section on Endocrinology
Section Editor-in-Chief: Dr. Jack V. Greiner for the section on Ophthalmology
2023–present Section Editor-in-Chief: Prof. Dr. Vassilios S. Nikolaou for the section on Orthopedics
Section Editor-in-Chief: Prof. Dr. Žilvinas Dambrauskas for the section on Surgery
Section Editor-in-Chief: Dr. Davide Bolignano for the section on Urology & Nephrology
Section Editor-in-Chief: Dr. Vishal G. Shelat for the section on Gastroenterology & Hepatology
Section Editor-in-Chief: Dr. Stefanie Krick for the section on Pulmonary
2024–present Section Editor-in-Chief: Dr. Edward A. Bittner for the section on Intensive Care/ Anesthesiology
Section Editor-in-Chief: Prof. Dr. Vita Maciulskiene for the section on Dentistry
Section Editor-in-Chief: Prof. Dr. Paola Savoia for the section on Dermatology
2025–present Section Editor-in-Chief: Dr. Henrik Falhammar for the section on Endocrinology
Section Editor-in-Chief: Prof. Dr. Stephen G. Schwartz for the section on Ophthalmology
2026–present Section Editor-in-Chief: Prof. Dr. Lukas Lusuardi for the section on Urology & Nephrology
XFacebookLinkedIn
Medicina - ISSN 1648-9144
Imprint
Download Flyer